| Literature DB >> 33014121 |
Ilker Ozsahin1,2, Boran Sekeroglu2,3, Musa Sani Musa1, Mubarak Taiwo Mustapha1,2, Dilber Uzun Ozsahin1,2.
Abstract
The COVID-19 diagnostic approach is mainly divided into two broad categories, a laboratory-based and chest radiography approach. The last few months have witnessed a rapid increase in the number of studies use artificial intelligence (AI) techniques to diagnose COVID-19 with chest computed tomography (CT). In this study, we review the diagnosis of COVID-19 by using chest CT toward AI. We searched ArXiv, MedRxiv, and Google Scholar using the terms "deep learning", "neural networks", "COVID-19", and "chest CT". At the time of writing (August 24, 2020), there have been nearly 100 studies and 30 studies among them were selected for this review. We categorized the studies based on the classification tasks: COVID-19/normal, COVID-19/non-COVID-19, COVID-19/non-COVID-19 pneumonia, and severity. The sensitivity, specificity, precision, accuracy, area under the curve, and F1 score results were reported as high as 100%, 100%, 99.62, 99.87%, 100%, and 99.5%, respectively. However, the presented results should be carefully compared due to the different degrees of difficulty of different classification tasks.Entities:
Mesh:
Year: 2020 PMID: 33014121 PMCID: PMC7519983 DOI: 10.1155/2020/9756518
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.238
COVID-19/normal classification results. Class.: classification; bac. pneu.: bacterial pneumonia; Sens.: sensitivity; Spec.: specificity; Prec.: precision; Acc.: accuracy; AUC: area under the curve; Ref.: reference.
| Class. | Subjects | Dataset | Method | Sens. (%) | Spec. (%) | Prec. (%) | Acc. (%) | AUC (%) | F1-score | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19/normal | 178 pneumonia | Private + | DL | N/A | N/A | N/A | 98.78 | N/A | 98.85 | Alom et al. [ |
| COVID-19/normal | 521 COVID-19 | [ | DL | 90.52 | 91.58 | N/A | 91.21 | 96.89 | N/A | Hu et al. [ |
| COVID-19/normal | 106 COVID-19 | Private + | DL | 98.2 | 92.2 | N/A | N/A | 99.6 | N/A | Gozes et al. [ |
| COVID-19/normal | COVID-19: X-ray:117; CT:20 | [ | DenseNet121 | 99.00 | N/A | 99.00 | 99.00 | N/A | 99.00 | Kassani et al. [ |
| COVID-19/normal | 1,262 COVID-19 | [ | DenseNet201 | 96.29 | 96.21 | 96.29 | 96.25 | 97.0 | 96.29 | Jaiswal et al. [ |
COVID-19/non-COVID-19 classification results. Class.: classification; Sens.: sensitivity; Spec.: specificity; Prec.: precision; Acc.: accuracy; AUC: area under the curve; Ref.: reference.
| Class. | Subjects | Dataset | Method | Sens. (%) or recall | Spec. (%) | Prec. (%) | Acc. (%) | AUC (%) | F1-score | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19/ | 496 COVID-19 | Private + [ | CNN | 94.06 | 95.47 | N/A | 94.98 | 97.91 | NA | Jin et al. [ |
| COVID-19/ | N/A | [ | CNN | ~90 | ~90 | N/A | ~90 | Not clear | ~90 | Singh et al. [ |
| COVID-19/ | 449 COVID-19 | Private + | DL multitask | 94 | 79 | N/A | 86 | 93 | N/A | Amyar et al. [ |
| COVID-19/ | 349 COVID-19 | Private + [ | ResNet18 | 100.0 | 98.6 | N/A | 99.4 | 99.65 | 99.5 | Ahuja et al. [ |
| COVID-19/ | 564 COVID-19 | [ | VGG16 based | 88.8 | N/A | 87.9 | 88.6 | 94.0 | 87.9 | Liu et al. [ |
| COVID-19/ | 53 COVID-19 | Not clear | SVM | 97.56 | 99.68 | 99.62 | 98.71 | N/A | 98.58 | Barstugan et al. [ |
| COVID-19/ | 313 COVID-19 | Private | UNet | 90.7 | 91.1 | N/A | 90.1 | 95.9 | N/A | Wang et al. [ |
| COVID-19/ | 51 COVID-19 | Private | UNet++ | 94.34 | 99.16 | N/A | 98.85 | N/A | N/A | Chen et al. [ |
| COVID-19/ | 723 COVID-19 | Private | UNet++ | 97.4 | 92.2 | N/A | N/A | 99.1 | N/A | Jin et al. [ |
| COVID-19/ | 413 COVID-19 | [ | ResNet-50 | 91.46 | 94.78 | 95.19 | 93.02 | N/A | N/A | Pathak et al. [ |
| COVID-19/ | 460 COVID-19 | [ | CNN | 85.00 | 81.00 | 81.73 | 83.00 | N/A | 83.33 | Polsinelli et al. [ |
| COVID-19/ | 230 COVID-19 | Private | AD3D-MIL | 97.9 | NA | 97.9 | 97.9 | 99.0 | 97.9 | Han et al. [ |
| COVID-19/ | 1029 COVID-19 | Private | AH-Net | 84.0 | 93.0 | NA | 90.8 | 94.9 | NA | Harmon et al. [ |
COVID-19/non-COVID-19 pneumonia classification results. Class.: classification; bac. pneu.: bacterial pneumonia; Sens.: sensitivity; Spec.: specificity; Prec.: precision; Acc.: accuracy; AUC: area under the curve; Ref.: reference.
| Class. | Subjects | Dataset | Method | Sens. (%) or recall | Spec. (%) | Prec. (%) | Acc. (%) | AUC (%) | F1-score | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19/influ-A/normal | 219 COVID-19 | Private | CNN | 86.7 | N/A | 81.3 | N/A | N/A | 83.9 | Xu et al. [ |
| COVID-19/CT-EGFR | 1266 COVID-19 | Private | COVID19Net (DenseNet-like str.) | 79.35 | 71.43 | N/A | 85.00 | 86.00 | 90.11 | Wang et al. [ |
| COVID-19/other pneu. | 521 COVID-19 | [ | DL | 85.71 | 84.88 | N/A | 85.40 | 92.22 | N/A | Hu et al. [ |
| COVID-19/other pneu. | 521 COVID-19 | Private | DNN | 95 | 96 | N/A | 96 | 95 | N/A | Bai et al. [ |
| COVID-19/CAP | 1495 COVID-19 | Private | Multiview representation learning | 96.6 | 93.2 | N/A | 95.5 | NA | N/A | Kang et al. [ |
| COVID-19/CAP | 1658 COVID-19 | Private | RF-based ML model | 90.7 | 83.3 | N/A | 87.9 | 94.2 | N/A | Shi et al. [ |
| COVID-19/bac. pneu./normal | 88 COVID-19 | Private | DRE-Net | 96 | N/A | 79 | 86 | 95 | 87 | Ying et al. [ |
| COVID-19/other pneu./non-pneu. | 230 COVID-19 | Private | AD3D-MIL | 90.5 | NA | 95.9 | 94.3 | 98.8 | 92.3 | Han et al. [ |
| COVID-19/other pneu./non-pneu. | 1194 COVID-19 | Private + | FCONet | 99.58 | 100.0 | NA | 99.87 | 100.0 | NA | Ko et al. [ |
| COVID-19/other pneu./non-pneu. | 1292 COVID-19 | Private | COVNet | 90 | 96 | NA | NA | 96.0 | NA | Li et al. [ |
| COVID-19/other pneu./healthy | 3854 COVID-19 | Private | MVPNet | 100 | 25 | NA | 94 | NA | 97.0 | Ni et al. [ |
COVID-19 severity classification results. Class.: classification; Sens.: sensitivity; Spec.: specificity; Prec.: precision; AUC: area under the curve; Ref.: reference.
| Class. | Subjects | Dataset | Method | Sens. (%) or recall | Spec. (%) | Prec. (%) | AUC (%) | Ref. |
|---|---|---|---|---|---|---|---|---|
| COVID-19 severe/nonsevere | 23,812 COVID-19 | Private | ResNet34 | N/A | N/A | 81.3 | 98.7 | Xiao et al. [ |
| COVID-19 severity score | 131 COVID-19 | [ | CNN | N/A | N/A | NA | NA | Zhu et al. [ |
| COVID-19 severity and progression | 72 COVID-19 | Private | UNet | 95 | 84 | N/A | N/A | Pu et al. [ |